Clinical Trial Update: Phase 1 PK Study of XOMA 3AB [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study of XOMA 3AB for botulism sponsored by NIAID has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Botulism

Drugs mentioned

• XOMA 3AB

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Botulism | Phase 1 | Status: COMPLETED